ALEXANDRIA, Va., Feb. 17 -- United States Patent no. 12,552,788, issued on Feb. 17, was assigned to ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (New York) and UNIVERSITEIT GENT (Ghent, Belgium).
"IMDQ-PEG-CHOL adjuvant and uses thereof" was invented by Adolfo Garcia-Sastre (New York), Michael Schotsaert (New York), Angela Choi (Boston), Bruno De Geest (De Pinte, Belgium) and Jana De Vrieze (Lievegem, Belgium).
According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are lipidated imidazoquinoline compounds and compositions comprising such compounds. The lipidated imidazoquinoline compounds may be used as an adjuvant to enhance to immune response elicited by an antigen of interest. Accordingly, also provided ...